OvationLab conducted a 100-person patient-reported outcome study that looked at how BPC-157 in the oral supplement form supported those with chronic musculoskeletal needs
Cancer Cell (2022) 40(4):36578.e6
They are awaiting grant of a patent by the US Food and Drug Administration to be used for the treatment of melasma, freckles, lentigines and postinflammatory hyperpigmentation
This kind of trial is expensive typically several million dollars and to date has been more difficult to justify economically because GHK-Cu cannot be patented as a novel drug (the molecule is endogenous and the relevant patents have expired)
It is unlikely to hurt is not evidence that it works. A well-tolerated ingredient with no proven hair-growth efficacy is exactly that: safe and unproven
Product configurations commonly include lyophilized GHK-Cu powder in sealed glass vials, with labeling that documents peptide content (e.g., 50 mg or 100 mg), suggested reconstitution volumes, and research-use disclaimers